Michael Zinner: The Malignant Hematology/Blood and Marrow Transplant Program at Miami Cancer Institute is the first in the nation to achieve accreditation with distinction from the American Nurses Credentialing Center’s Commission on Accreditation in Practice Transition Programs
Michael Zinner, CEO and Executive Medical Director of Miami Cancer Institute and Baptist Health Cancer Care, shared a post by Baptist Health on Linkedin, adding:
“I am honored to share that our team at Miami Cancer Institute’s Malignant Hematology/BMT Program has made history as the first in the nation to achieve accreditation with distinction from the American Nurses Credentialing Center’s Commission on Accreditation in Practice Transition Programs! This milestone speaks volumes about our dedication to providing the utmost quality care for patients with hematological conditions. Proud to be part of a team committed to excellence!”
Quoting Baptist Health’s post:
“We’re excited to announce the Malignant Hematology/Blood and Marrow Transplant Program at Miami Cancer Institute is the first in the nation to achieve accreditation with distinction from the American Nurses Credentialing Center’s (part of the American Nurses Association) Commission on Accreditation in Practice Transition Programs for our Advanced Practice Providers Fellowship Program.
‘This accreditation validates the quality of the care we can provide for our patients,’ said Jannelle Vicens, nurse practitioner for bone marrow transplant, malignant hematology, and HIV oncology and program co-director of the Fellowship, along with physician assistant Victoria Cassidy. ‘It ensures the growing number of patients with malignant hematological conditions will continue to have access to high-quality care through Advanced Practice Providers (APPs) , specifically certified to care for their diseases,’ Vicens said.
The program is the first in the United States to earn this accreditation, ensures the growing number of patients with malignant hematological conditions will continue to have access to high-quality care through APPs, specifically certified to care for their diseases.”
Learn more.
Source: Michael Zinner/Linkedin and Baptist Health/Linkedin
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023